Personalizing IBD Management: Utilizing Precision Medicine and Innovative Therapies – Tuesday, May 20, 2025

Join us for a live webcast on inflammatory bowel disease!

Tuesday, May 20, 2025
7:00 PM – 8:00 PM EDT
6:00 PM – 7:00 PM CDT
4:00 PM – 5:00 PM PDT

Course Information
PROVIDER STATEMENT

  

Provided by Integrity CE, LLC.
Provided in partnership with the Georgia Gastroenterologic and Endoscopic Society.

DISCLOSURE OF COMMERCIAL SUPPORT

Supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC and Takeda Pharmaceuticals U.S.A., Inc.

PROGRAM OVERVIEW

The emergence of biologic and small-molecule therapies offers new opportunities for effective treatment of inflammatory bowel disease (IBD), yet the lack of predictive biomarkers and the diverse nature of treatment responses pose significant challenges. Education on precision medicine, integration of patient-reported outcomes, and a deep understanding of the latest therapeutic options are essential to optimize patient care. By enhancing knowledge and skills in these areas, healthcare professionals can better align treatment strategies with patient needs, improve clinical outcomes, and reduce overall healthcare costs associated with IBD. With the increasing global prevalence and complex nature of IBD, encompassing ulcerative colitis (UC) and Crohn’s disease (CD), the healthcare burden is substantial and growing. This targeted education is not only crucial for improving patient quality of life but also for advancing the field of IBD management.

Learning Objectives
TARGET AUDIENCE

This educational activity has been designed for gastroenterologists and other healthcare professionals who manage patients with IBD.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

  • Define precision medicine and discuss its plausible application in clinical scenarios to optimize the care and treatment of patients with inflammatory bowel disease
  • Integrate patient-reported outcomes into clinical practice to ensure shared-decision making and patient-centric care in UC and CD
  • Describe the rationale for and clinical data supporting the mechanism of action, efficacy, and safety of approved biologic and small molecular drugs for the treatment of UC and CD
Faculty Information and Disclosures
FACULTY PRESENTERS
Marla C. Dubinsky, MD (Program Chair)
Chief, Pediatric Gastroenterology & Hepatology
Co-Director, Susan and Leonard Feinstein IBD Clinical Center
Mount Sinai Hospital
New York, New York

Faculty Co-Presenter to be announced shortly

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity CE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any financial relationships with ineligible companies. All identified relevant financial relationships are thoroughly vetted by Integrity CE, LLC for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated.

The following faculty/planners reported the financial relationships or relationships to products or devices they have with ineligible companies related to the content of these CME activities:

Faculty Speakers will present their disclosures prior to the live presentation.

The Integrity CE, LLC planners and managers do not have any relevant financial relationships or relationships to products or devices with ineligible companies.

Accreditation Information
DIRECTIONS TO LEARNER

There are no fees for participating and receiving CME credit for this activity. To receive credit, participants must:

  • Complete the pretest
  • View the live webcast
  • Complete the posttest and evaluation form at the end of the program

A statement of credit will be issued only upon receipt of a completed activity evaluation form. Certificates will be sent via email within four weeks of receipt of the competed evaluation form.

ACCREDITATION STATEMENT


Integrity CE, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION

Integrity CE, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity CE, LLC at (855) 835-4004 or cme@integrityce.com.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity CE, LLC does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimers and Technical Requirements
PRIVACY POLICY

When you participate in an online educational activity sponsored by Integrity CE, LLC, you will be asked for your name, degree(s), affiliation(s), street address, telephone number and…(continued)

MINIMUM SYSTEM REQUIREMENTS

Minimum Processor: Intel Pentium 4, 2.33 + GHz (or equivalent)
Operating Systems: Windows XP, Windows 2000, Windows Vista, Windows 7, Windows 10, and Mac OS
Plug-in: Adobe® Flash® Player 10

  • Adobe® Flash® Player 10 plug-in should be downloaded
  • Click on the “Agree and install now” button after unchecking the optional McAfee Security Scan Plus

For optimal performance, the use of Internet Explorer below 8 is not recommended

For a full listing of recommended operating systems, browsers, and system configurations, please click on the link below:
Click here for more information on minimum system requirements

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Agenda

On the day of the webcast, you can access the event at this link: https://integrityce.com/IBDWebcast1

There are no fees for participating and receiving CME credit for this activity. For your participation, you will be able to receive a maximum of 1.0 AMA PRA Category 1 CME Credit™. To do so, you must participate in the webcast and complete the posttest and evaluation form following the live event. A statement of credit will be issued via email within four weeks of submission of a completed activity evaluation form.